Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06448754
Status:
RECRUITING
Last Update Posted:
2024-07-09
First Post:
2024-06-04
Brief Title:
Volrustomig Priming Regimens Exploratory Phase II Platform Study
Sponsor:
Organization:
AstraZeneca